Google’s Pixel Watch 5 arrives with a $50 price hike to $399, a satin pyrite finish, and a Steph Curry Special Edition. The processor is slightly faster and the battery marginally bigger. But the hardware story ends there. Everything meaningful this year is software.
The headline addition is Breathing Emergency Detection, an extension of last year’s Loss of Pulse feature. When the watch detects SpO2 dropping to roughly 83 percent for an extended period, it triggers an emergency call and alerts designated contacts. Heart rate, motion, and altitude sensors work together to filter false positives, and the feature disables after 30 minutes of detected sleep to avoid sleep apnea false alarms. It launches in Europe on Pixel Watch 4 and 5, but remains pending FDA clearance in the US. Google is explicit that it’s not for people with chronic respiratory conditions — it’s aimed at acute breathing emergencies.
Gemini on the wrist gets offline capabilities for simple tasks like timers and app launching, though my demo showed noticeably slower response times without a connection. Proactive suggestions now surface contextually — a text asking about availability prompts a Calendar check from the watch face. There’s also a live information icon for timers, Uber ETAs, and workouts. The AI watchface generator, powered by the Nano Banana model, is more gimmick than utility. I asked for “fat cats and an elegant font” and got plump cat-shaped clock numbers instead.
Blood Pressure Trends and Insulin Resistance Trends arrive in September, not at launch. Both are wellness features, not diagnostics — Google calls them “check engine light” warnings. They need at least a week of data and flag trends monthly. Blood pressure estimates come from optical heart rate and motion sensors feeding an AI model that tracks pulse wave shape and speed. There are no systolic or diastolic readings. Insulin resistance tracking is genuinely new territory for wearables — Apple and Whoop have dipped into blood pressure insights, but nobody has attempted non-invasive insulin resistance estimation. Untreated insulin resistance leads to fatigue, weight gain, and eventually Type 2 diabetes, so the potential audience is enormous. The question is whether a wrist-worn optical sensor can deliver meaningful signal without drowning users in false alarms. Google’s own cautious framing — trends, not diagnoses, monthly flags, not daily alerts — suggests the company knows exactly how much trust this feature needs to earn.
